Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19

DPP-4Is are well recognized therapy for type 2 diabetes. In spite of sharing a common mode of action, the chemical diversity among members of DPP‐4Is raised the question whether structural differences may result in distinguished activities. DPP-4Is were recently explored as drug repurposing means fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahgoub, Shahenda, Fatahala, Samar S., Sayed, Amira I., Atya, Hanaa B., El-Shehry, Mohamed F., Afifi, Hala, Awad, Samir M., El-Hameed, Rania H. Abd, Taha, Heba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364673/
https://www.ncbi.nlm.nih.gov/pubmed/35985159
http://dx.doi.org/10.1016/j.bioorg.2022.106092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364673/
https://www.ncbi.nlm.nih.gov/pubmed/35985159
http://dx.doi.org/10.1016/j.bioorg.2022.106092

Ejemplares similares